REVANCE THERAPEUTICS INC

CUSIP: 761330AB5 Class: NOTE 1.750% 2/1

Amundi's Holding History (CIK: 0001330387)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 3,432,000 Value ($000) $3,301 Avg Close — Range —
Q3 2024
Shares 3,432,000 Value ($000) $2,907 Avg Close — Range —
Q2 2024
Shares 3,432,000 Value ($000) $2,251 Avg Close — Range —
Q1 2024
Shares 3,432,000 Value ($000) $2,385 Avg Close — Range —
Q4 2023
Shares 3,432,000 Value ($000) $2,492 Avg Close — Range —
Q3 2023
Shares 3,432,000 Value ($000) $2,608 Avg Close — Range —
Q2 2023
Shares 3,432,000 Value ($000) $3,593 Avg Close — Range —
Q1 2023
Shares 6,232,000 Value ($000) $7,768 Avg Close — Range —
Q4 2022
Shares 6,232,000 Value ($000) $6,812 Avg Close — Range —
Q3 2022
Shares 6,232,000 Value ($000) $7,043 Avg Close — Range —
Q2 2022
Shares 6,232,000 Value ($000) $5,145 Avg Close — Range —
Q1 2022
Shares 6,232,000 Value ($000) $5,916 Avg Close — Range —
Q4 2021
Shares 6,232,000 Value ($000) $5,375 Avg Close — Range —
Q3 2021
Shares 6,232,000 Value ($000) $7,157 Avg Close — Range —